Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ocera Therapeutics's Enterprise Value is $47.49 Mil.
Ocera Therapeutics's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 was $-23.18 Mil. Therefore, Ocera Therapeutics's EV-to-EBIT ratio for today is -2.05.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ocera Therapeutics's Enterprise Value is $47.49 Mil.
Ocera Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2017 was $-23.14 Mil. Therefore, Ocera Therapeutics's EV-to-EBITDA ratio for today is -2.05.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ocera Therapeutics's Enterprise Value is $47.49 Mil.
Ocera Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2017 was $0.51 Mil. Therefore, Ocera Therapeutics's EV-to-Revenue ratio for today is 92.75.
Ocera Therapeutics Enterprise Value Historical Data
The historical data trend for Ocera Therapeutics's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ocera Therapeutics's Enterprise Value
For the Biotechnology subindustry, Ocera Therapeutics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ocera Therapeutics's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ocera Therapeutics's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ocera Therapeutics's Enterprise Value falls into.
Ocera Therapeutics Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ocera Therapeutics's Enterprise Value for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocera Therapeutics (NAS:OCRX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ocera Therapeutics's current Enterprise Value is $47.49 Mil.
Ocera Therapeutics's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.18 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ocera Therapeutics's current Enterprise Value is $47.49 Mil.
Ocera Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.14 Mil.
Ocera Therapeutics's current Enterprise Value is $47.49 Mil.
Ocera Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocera Therapeutics Enterprise Value Related Terms
Thank you for viewing the detailed overview of Ocera Therapeutics's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Ocera Therapeutics (Ocera Therapeutics) Business Description
Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company, which primarily targets acute and chronic orphan liver diseases. The company is focused on the development and commercialization of a clinical product candidate, OCR-002 for the treatment of acute and chronic hepatic encephalopathy for patients with a serious complication of liver cirrhosis, or liver failure, marked by mental changes including confusion, impaired motor skills, disorientation in time and space, and, in its more severe form, stupor, coma and even death. All the business activity of the firm is functioned through the region of US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OCRX has been successfully added to your 